Venture Infusion Catheter
by Scimed Life Systems, Inc. 510(k)
Active
510(k) K931335
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK931335 | Date27 Jul 1994 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- Full name
- Scimed(R) Venture(Tm) Infusion Catheter
- 510(k) Number
- FDA Product Code
- KRA
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1210
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Venture Infusion Catheter is a continuous flush catheter designed for vascular access. It is intended for the administration of fluids, medications, or blood products while maintaining patency through continuous irrigation, reducing the risk of occlusion in central venous lines.
This device is supplied as a single-use, sterile product and is classified under FDA regulation 870.1210 as a Class II medical device. It is intended for use in cardiovascular settings, including intensive care units and operating rooms, and is compatible with MRI environments when specified. Multiple sizes and configurations are available, as indicated by the associated FEI numbers, and it requires proper storage to maintain sterility and functionality.
Other devices from Scimed Life Systems, Inc.
Questions
AI-generated answers, 19 Sep 2026
What clinical settings is the Venture Infusion Catheter primarily designed for, and why is this important for clinicians?
The Venture Infusion Catheter is designed for use in cardiovascular settings, including intensive care units (ICUs) and operating rooms. This is important because these environments require reliable vascular access for continuous administration of fluids, medications, or blood products while minimizing the risk of occlusion—a critical concern in critical care and surgical contexts.
Is the Venture Infusion Catheter compatible with MRI environments, and if so, how does this benefit patients?
Yes, the Venture Infusion Catheter is specifically compatible with MRI environments when used as intended. This compatibility is beneficial for patients who may require both vascular access and MRI imaging (e.g., for diagnostic or monitoring purposes) without the need to discontinue or replace the catheter, reducing disruption to their care.
Are there multiple sizes or configurations available for the Venture Infusion Catheter, and how does this affect its versatility?
Yes, the Venture Infusion Catheter comes in multiple sizes and configurations, as indicated by the associated FEI numbers (e.g., 3012543881, 3003495548, etc.). This variety allows clinicians to select the most appropriate catheter for different patient anatomies, vascular access points, or clinical needs, enhancing its versatility across diverse cardiovascular procedures.
How should the Venture Infusion Catheter be stored to maintain its sterility and functionality, and why is this important?
The Venture Infusion Catheter must be stored according to manufacturer guidelines to preserve sterility and functionality. Since it is a single-use, sterile product, improper storage (e.g., exposure to moisture, contamination, or extreme temperatures) could compromise its integrity before use. Proper storage ensures the catheter remains safe and effective for its intended purpose when opened for clinical use.
What regulatory pathway was followed for the Venture Infusion Catheter, and what does this mean for its use in clinical practice?
The Venture Infusion Catheter followed the FDA 510(k) Traditional pathway, with a substantially equivalent (SESE) determination by the Cardiovascular (CV) Advisory Committee. This means the device was reviewed for safety and effectiveness compared to a legally marketed predicate, ensuring it meets FDA standards for Class II medical devices under regulation 870.1210. Clinically, this indicates the catheter has undergone rigorous evaluation to support its use in vascular access for continuous infusion.